Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

May 30, 2026

Study Completion Date

October 30, 2026

Conditions
Locally Advanced Unresectable Pancreatic Adenocarcinoma
Interventions
COMBINATION_PRODUCT

Padeliporfin Vascular Targeted Photodynamic (VTP) therapy

The laser light fiber with inflatable balloon to dam SMA blood flow during light illumination will be placed by an Interventional Radiologist in the SMA via a transfemoral artery approach. The balloon will be inflated to impede blood flow for total of 10 minutes during light illumination

Trial Locations (2)

91010

RECRUITING

City of Hope, Duarte

92697

RECRUITING

University of California Irvine, Irvine

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Impact Biotech Ltd

INDUSTRY